TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Ovarian Cancer Drugs Market - By Drug Class
1.3.2 Ovarian Cancer Drugs Market - By Distribution Channel
1.3.3 Ovarian Cancer Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. OVARIAN CANCER DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. OVARIAN CANCER DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. OVARIAN CANCER DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. OVARIAN CANCER DRUGS - GLOBAL MARKET OVERVIEW
6.2. OVARIAN CANCER DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. OVARIAN CANCER DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. ALKYLATING AGENTS
7.3.1. Overview
7.3.2. Alkylating Agents Market Forecast and Analysis
7.4. MITOTIC INHIBITORS
7.4.1. Overview
7.4.2. Mitotic Inhibitors Market Forecast and Analysis
7.5. ANTIRHEUMATICS
7.5.1. Overview
7.5.2. Antirheumatics Market Forecast and Analysis
7.6. ANTIPSORIATICS
7.6.1. Overview
7.6.2. Antipsoriatics Market Forecast and Analysis
7.7. VEGF/VEGFR INHIBITORS
7.7.1. Overview
7.7.2. VEGF/VEGFR Inhibitors Market Forecast and Analysis
7.8. PARP INHIBITORS
7.8.1. Overview
7.8.2. PARP Inhibitors Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. OVARIAN CANCER DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis
9. OVARIAN CANCER DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Ovarian Cancer Drugs Market Overview
9.1.2 North America Ovarian Cancer Drugs Market Forecasts and Analysis
9.1.3 North America Ovarian Cancer Drugs Market Forecasts and Analysis - By Drug Class
9.1.4 North America Ovarian Cancer Drugs Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Ovarian Cancer Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Ovarian Cancer Drugs Market
9.1.5.1.1 Canada Ovarian Cancer Drugs Market by Drug Class
9.1.5.1.2 Canada Ovarian Cancer Drugs Market by Distribution Channel
9.1.5.2 Mexico Ovarian Cancer Drugs Market
9.1.5.2.1 Mexico Ovarian Cancer Drugs Market by Drug Class
9.1.5.2.2 Mexico Ovarian Cancer Drugs Market by Distribution Channel
9.1.5.3 US Ovarian Cancer Drugs Market
9.1.5.3.1 US Ovarian Cancer Drugs Market by Drug Class
9.1.5.3.2 US Ovarian Cancer Drugs Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Ovarian Cancer Drugs Market Overview
9.2.2 Europe Ovarian Cancer Drugs Market Forecasts and Analysis
9.2.3 Europe Ovarian Cancer Drugs Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Ovarian Cancer Drugs Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Ovarian Cancer Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Ovarian Cancer Drugs Market
9.2.5.1.1 Germany Ovarian Cancer Drugs Market by Drug Class
9.2.5.1.2 Germany Ovarian Cancer Drugs Market by Distribution Channel
9.2.5.2 France Ovarian Cancer Drugs Market
9.2.5.2.1 France Ovarian Cancer Drugs Market by Drug Class
9.2.5.2.2 France Ovarian Cancer Drugs Market by Distribution Channel
9.2.5.3 Italy Ovarian Cancer Drugs Market
9.2.5.3.1 Italy Ovarian Cancer Drugs Market by Drug Class
9.2.5.3.2 Italy Ovarian Cancer Drugs Market by Distribution Channel
9.2.5.4 Spain Ovarian Cancer Drugs Market
9.2.5.4.1 Spain Ovarian Cancer Drugs Market by Drug Class
9.2.5.4.2 Spain Ovarian Cancer Drugs Market by Distribution Channel
9.2.5.5 United Kingdom Ovarian Cancer Drugs Market
9.2.5.5.1 United Kingdom Ovarian Cancer Drugs Market by Drug Class
9.2.5.5.2 United Kingdom Ovarian Cancer Drugs Market by Distribution Channel
9.2.5.6 Rest of Europe Ovarian Cancer Drugs Market
9.2.5.6.1 Rest of Europe Ovarian Cancer Drugs Market by Drug Class
9.2.5.6.2 Rest of Europe Ovarian Cancer Drugs Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Ovarian Cancer Drugs Market Overview
9.3.2 Asia-Pacific Ovarian Cancer Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Ovarian Cancer Drugs Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Ovarian Cancer Drugs Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Ovarian Cancer Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Ovarian Cancer Drugs Market
9.3.5.1.1 Australia Ovarian Cancer Drugs Market by Drug Class
9.3.5.1.2 Australia Ovarian Cancer Drugs Market by Distribution Channel
9.3.5.2 China Ovarian Cancer Drugs Market
9.3.5.2.1 China Ovarian Cancer Drugs Market by Drug Class
9.3.5.2.2 China Ovarian Cancer Drugs Market by Distribution Channel
9.3.5.3 India Ovarian Cancer Drugs Market
9.3.5.3.1 India Ovarian Cancer Drugs Market by Drug Class
9.3.5.3.2 India Ovarian Cancer Drugs Market by Distribution Channel
9.3.5.4 Japan Ovarian Cancer Drugs Market
9.3.5.4.1 Japan Ovarian Cancer Drugs Market by Drug Class
9.3.5.4.2 Japan Ovarian Cancer Drugs Market by Distribution Channel
9.3.5.5 South Korea Ovarian Cancer Drugs Market
9.3.5.5.1 South Korea Ovarian Cancer Drugs Market by Drug Class
9.3.5.5.2 South Korea Ovarian Cancer Drugs Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Ovarian Cancer Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Ovarian Cancer Drugs Market by Drug Class
9.3.5.6.2 Rest of Asia-Pacific Ovarian Cancer Drugs Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Ovarian Cancer Drugs Market Overview
9.4.2 Middle East and Africa Ovarian Cancer Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Ovarian Cancer Drugs Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Ovarian Cancer Drugs Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Ovarian Cancer Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Ovarian Cancer Drugs Market
9.4.5.1.1 South Africa Ovarian Cancer Drugs Market by Drug Class
9.4.5.1.2 South Africa Ovarian Cancer Drugs Market by Distribution Channel
9.4.5.2 Saudi Arabia Ovarian Cancer Drugs Market
9.4.5.2.1 Saudi Arabia Ovarian Cancer Drugs Market by Drug Class
9.4.5.2.2 Saudi Arabia Ovarian Cancer Drugs Market by Distribution Channel
9.4.5.3 U.A.E Ovarian Cancer Drugs Market
9.4.5.3.1 U.A.E Ovarian Cancer Drugs Market by Drug Class
9.4.5.3.2 U.A.E Ovarian Cancer Drugs Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Ovarian Cancer Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Ovarian Cancer Drugs Market by Drug Class
9.4.5.4.2 Rest of Middle East and Africa Ovarian Cancer Drugs Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Ovarian Cancer Drugs Market Overview
9.5.2 South and Central America Ovarian Cancer Drugs Market Forecasts and Analysis
9.5.3 South and Central America Ovarian Cancer Drugs Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Ovarian Cancer Drugs Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Ovarian Cancer Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Ovarian Cancer Drugs Market
9.5.5.1.1 Brazil Ovarian Cancer Drugs Market by Drug Class
9.5.5.1.2 Brazil Ovarian Cancer Drugs Market by Distribution Channel
9.5.5.2 Argentina Ovarian Cancer Drugs Market
9.5.5.2.1 Argentina Ovarian Cancer Drugs Market by Drug Class
9.5.5.2.2 Argentina Ovarian Cancer Drugs Market by Distribution Channel
9.5.5.3 Rest of South and Central America Ovarian Cancer Drugs Market
9.5.5.3.1 Rest of South and Central America Ovarian Cancer Drugs Market by Drug Class
9.5.5.3.2 Rest of South and Central America Ovarian Cancer Drugs Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. OVARIAN CANCER DRUGS MARKET, KEY COMPANY PROFILES
11.1. ABBVIE INC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASTRAZENECA
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. F. HOFFMANN-LA ROCHE LTD
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. PFIZER, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MERCK SHARP AND DOHME CORP
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. IMMUNOGEN, INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. CLOVIS ONCOLOGY
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. GLAXOSMITHKLINE, PLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. AMGEN INC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
"
The List of Companies
- AstraZeneca
- AbbVie Inc
- F. Hoffmann-La Roche Ltd
- Pfizer, Inc.
- Merck Sharp and Dohme Corp
- ImmunoGen, Inc
- CLOVIS ONCOLOGY
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline, Plc
- Amgen Inc
- Oasmia Pharmaceuticals
- Bayer
- Lilly
- Bristol-Myers Squibb
Get the Latest COVID-19 Analysis on this market